Terns Pharmaceuticals Income Statement (2020-2023) | TERN

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating items
Research & Development (Quarter) 7.24M7.61M5.40M7.77M8.73M5.96M7.15M9.46M2.20M37.42M63.50M
Selling, General & Administrative (Quarter) 2.18M2.49M3.33M1.00M4.56M4.86M4.71M5.42M5.69M5.42M5.13M6.17M
Other Operating Expenses (Quarter) 8.14M8.66M9.96M-26.76M
Operating Expenses (Quarter) 9.42M10.10M8.74M8.77M13.30M10.82M11.87M14.88M13.82M14.08M17.29M16.83M63.50M
Operating Income (Quarter) -9.42M-10.10M-8.74M-8.77M-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M
EBIT (Quarter) -9.42M-10.10M-8.74M-8.77M-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M-21.47M-17.82M-29.71M-20.97M
Non-operating items
Interest & Investment Income (Quarter) 0.05M0.00M0.00M0.00M0.01M0.06M0.05M0.06M0.07M0.21M0.50M1.33M
Other Non Operating Income (Quarter) 0.17M0.25M-0.39M0.07M-0.01M0.04M0.00M0.01M0.00M-0.05M-0.01M-0.00M
Non Operating Income (Quarter) 0.22M0.25M-0.39M-2.76M-0.01M0.04M0.00M0.01M0.00M-0.05M0.48M-0.79M
Net income details
EBT (Quarter) -9.21M-9.85M-11.49M31.72M-13.30M-10.72M-11.81M-13.90M-13.75M-13.92M-16.81M-15.50M-21.47M-17.82M-29.71M-20.97M
Tax Provisions (Quarter) 0.10M0.71M0.04M0.01M0.02M0.35M0.02M0.01M0.01M0.32M0.06M0.07M0.06M0.05M
Profit After Tax (Quarter) -9.00M-9.69M-11.59M-10.45M-13.34M-10.74M-11.84M-14.25M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Income from Non-Controlling Interests (Quarter) -0.20M-0.16M-0.13M-0.03M
Income from Continuing Operations (Quarter) -9.21M-9.85M-11.59M31.01M-13.34M-10.74M-11.84M-14.24M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Consolidated Net Income (Quarter) -9.21M-9.85M-11.59M31.01M-13.34M-10.74M-11.84M-14.24M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Income towards Parent Company (Quarter) -9.21M-9.85M-11.59M31.01M-13.34M-10.74M-11.84M-14.24M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Net Income towards Common Stockholders (Quarter) -9.21M-9.85M-11.59M31.01M-13.34M-10.74M-11.84M-14.24M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Additional items
EPS (Basic) (Quarter) -33.09-33.09-37.828.45-0.43-0.43-0.47-0.57-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29
EPS (Weighted Average and Diluted) (Quarter) -0.54-0.63-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29
Shares Outstanding (Weighted Average) (Quarter) 0.22M0.29M0.27M0.29M15.16M20.16M21.84M22.71M25.27M25.29M29.74M36.03M69.78M70.58M71.53M
Shares Outstanding (Diluted Average) (Quarter) 21.84M22.71M25.27M25.29M29.74M36.03M69.78M70.58M71.53M
EBITDA (Quarter) -9.38M-9.83M-11.23M-8.77M-13.45M-10.68M-11.83M-13.88M-14.33M-14.28M-16.93M-16.83M-21.12M-18.25M-29.83M-20.97M
Tax Rate (Quarter) -0.89%2.24%-0.29%-0.13%-0.17%-2.49%-0.15%-0.04%-0.08%-2.05%-0.28%-0.40%-0.20%-0.23%